Clinical trial
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
NCT03891446
Study timeline
Study start (actual)2019-03-27Date precision: day
Registry last updated2026-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Open-Angle Glaucomaunresolved
Ocular Hypertensionunresolved
Interventions
Bimatoprost SRDRUG
Standard of CareOTHER
Sponsors & collaborators
AbbVielead sponsor
Mapped research locations
San AntonioTexas, United States3HaifaIsrael3TampaFlorida, United States2CairoEgypt2HoustonTexas, United States1ChicagoIllinois, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1NashvilleTennessee, United States1SeoulSouth Korea1San FranciscoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03891446 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.